Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

These breakthrough diabetes and weight-loss medications have transformed millions of lives, but not everyone responds in the ...

People with type 2 diabetes (T2D) in England could be offered earlier access to newer treatments, including weight-loss jabs, under draft guidance from the National Institute for Health and Care ...

New data documented dramatic shifts in prescribing for both type 2 diabetes (T2D) and weight loss, particularly with the uptake of tirzepatide (Lilly) and declines in the use of older agents. Between ...

Tsukuba, Japan—Patients with low skeletal muscle mass are at a higher risk of falling. Certain diabetes medications, particularly SGLT2 (SGLT2) inhibitors and GLP-1 (GLP-1) receptor agonists, are ...

You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ...

Please provide your email address to receive an email when new articles are posted on . Overall, 44% of the calorie restriction and dapaglifozin treatment group achieved diabetes remission compared ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and kidney complications, and in the majority of ...